id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-322861-q7uk6rdp	Zanon, Ezio	How haemophilia A impacts severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) treatment: a case report	2020-07-16		.txt	text/plain	2114	113	45	Even if much more data are needed to ascertain the real thrombotic risk of haemophilia A in COVID-19 patients, it's clear that the FVIII and vWF should be strictly monitored in order to promptly establish an adequate treatment and avoid the onset of thromboembolic events, even fatal, causing many deaths in COVID-19 patients. The Italian Society on Thrombosis and Haemostasis (SISET) suggests tailoring the therapy on the patient's characteristics, using intermediate or therapeutic dosages of anticoagulants according to the pre-existing thromboembolic risk factors and to maintain the treatment for the duration of the hospitalization and, in the cases at high risk for VTE, even at discharge (5) . Here we are reporting a case of an elderly Italian patient with mild haemophilia A who was hospitalized with severe acute respiratory syndrome coronavirus 2 (Sars-Cov-2). Our case showed that patients with mild haemophilia A presented a clinical course of COVID-19 similar to that of non-haemophilic patients, as coagulation parameters changed towards hypercoagulability as well (9) .	./cache/cord-322861-q7uk6rdp.txt	./txt/cord-322861-q7uk6rdp.txt